• Facebook
  • X
  • Instagram
  • RSS
  • Advertise
  • TradeIQ Concert
  • Research Reports
  • Heatmap
  • Billionaires
  • Entrepreneurs
  • Entertainment
  • Banking
  • Gold & Metals
  • Real Estate
  • Crypto Press Release
0 Items
Trade Brains
  • Indian Markets
    • Editors Pick
    • Bulk/Block Deals
    • Corporate Action
    • Large-cap
    • Mid-cap
    • Micro-Penny
    • Recent Orders
    • IPO Analysis
    • Results
    • FPO Analysis
    • Stock Ideas
    • Technical
  • Global Markets
    • US Markets
    • Trump News
    • Asian Markets
    • European Markets
  • Digital Assets
    • Crypto
    • NFT
  • Business
    • Billionaires
    • Entrepreneurs
    • Fintech
    • Innovation
    • Leadership
    • Startups
  • Money
    • Gold & Metals
    • Banking
    • Credit Card
    • Mutual Funds
    • ETFs
    • Hedge Funds
    • Insurances
    • Real Estate
    • Retirement
    • Personal Finance
  • Lifestyle
  • Sports
Select Page
Pharma stock jumps 10% after USFDA clears company’s Hyderabad facility with zero observations

Pharma stock jumps 10% after USFDA clears company’s Hyderabad facility with zero observations

by Trade Brains | August 28, 2025 11:22 am | Analysis, Indian Markets, News, Small-cap, Stocks

Synopsis: SMS Pharmaceuticals announced the successful closure of USFDA inspection at its Hyderabad lab. Conducted June 23-25, 2025, the audit ended with zero Form 483 observations; EIR issued with “No Action Indicated” status. During Thursday’s trading session,...
Pharma stock falls after CITI maintains ‘sell’ rating for downside of 25%

Pharma stock falls after CITI maintains ‘sell’ rating for downside of 25%

by Trade Brains | June 26, 2025 11:45 am | Indian Markets, Large-cap, News, Stocks

During Thursday’s trading session, the shares of a global pharmaceutical company providing access to affordable and innovative medicines tumbled by nearly 2 percent on BSE, after CITI Research trimmed target price and recommended a “sell” rating on the...
Pharma stock jumps after receiving approval for its diabetes drug

Pharma stock jumps after receiving approval for its diabetes drug

by Trade Brains | June 3, 2025 11:47 am | Indian Markets, Mid-cap, News, Stocks

Shares of a leading pharmaceutical company rose nearly 2 percent in today’s trading session after the firm announced it had secured regulatory approval for its new diabetes drug. The development marks a significant milestone in the company’s efforts to expand its...
Pharma stock jumps 8% after company forecasts 20% revenue growth

Pharma stock jumps 8% after company forecasts 20% revenue growth

by Trade Brains | May 29, 2025 5:39 pm | Indian Markets, News, Small-cap, Stocks

A leading pharmaceutical company witnessed an 8 percent surge in its stock price after unveiling ambitious plans to achieve 20 percent revenue growth, coupled with expectations of improved margins. The upbeat outlook has sparked strong investor interest, reflecting...
Pharma Stocks With High Dividend Yield – List And Insights

Pharma Stocks With High Dividend Yield – List And Insights

by Trade Brains | May 2, 2024 8:00 am | Case Study, Stocks

Pharma Stocks With High Dividend Yield: Pharmaceutical companies discover, develop, manufacture, and market drugs for human and veterinary use. The sector is comprised of innovator/research companies that focus on new drug discovery and generic drug makers that...
Candlesticks and chart trading mastery

Search Topic or Keyword

Easiest Stock Screener Tool!

Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.

  • — Stock Screener
  • — Compare Stocks
  • — Stock Buckets
  • — Portfolio Backtesting

Start your stock analysis journey with Trade Brains Portal today. Launch here!

Keep the Learning On!

Subscribe to Youtube to watch our latest stock market videos. Subscribe here.

About Trade Brains

Trade Brains is India’s trusted financial and business news portal.

Phone: 080884 91790

Email: [email protected]

Quick Links

  • Trade Brains Portal
  • Stock Screener
  • Compare Stocks
  • Trade Brains News
  • Candlesticks Books
  • Fingrad
  • Subscribe on Youtube

Contact and Partnership

Reach us out at

  • Phone: [+91] 8088491790
  • Email: [email protected]

For Advertisement, Press Releases, Partnerships or to get backlinks on this website, please e-mail us at [email protected]

For Partnerships & Promotio

Visit  – tradebrainsawards.com/

Chandan Singh Rawat
Emaill: [email protected]
Mob: (+91)6366648573

Bikram Singhary
Email: [email protected]
Mob: (+91)8088491790

Other Links

  • Upcoming Dividend Stocks
  • Upcoming Bonus Issue
  • Nifty 50 Heatmap
  • Stock Research Reports
  • Trending Stocks Today
  • Stock Comapre
  • Newsslash

 

 

  • About
  • Careers
  • Advertise & Backlinks
  • Terms and Conditions
  • Disclaimer & Privacy Policy
  • Contact
  • Submit Press Release
  • Facebook
  • X
  • Instagram
  • RSS
2025 © Tradebrains Technologies Pvt Ltd - All Right Reserved